Showing results (41-50 of 288) with videos related to
Sort By:
Pageof 29
Best Practice & Research. Clinical Haematology|November 21, 2017
AML in 2017: Advances in clinical practiceJacob M RoweRambam Maimonides Medical Journal|August 3, 2013
Interpreting outcome data in hematological malignancies: a paradigm for clinical studiesJacob M RoweBiology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2011
Interpreting data on transplant selection and outcome in adult acute lymphoblastic leukemia (ALL)Jacob M RoweBest Practice & Research. Clinical Haematology|December 5, 2009
Is there a role for intensifying induction therapy in acute myeloid leukaemia (AML)?Jacob M RoweBest Practice & Research. Clinical Haematology|November 30, 2019
Will new agents impact survival in AML?Jacob M RoweAmerican Journal of Hematology|October 6, 2015
Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3 + 7" induction regimen for acute myeloid leukemiaYishai Ofran, Ronit Leiba, Chezi Ganzel, et al.American Journal of Infection Control|November 27, 2013
Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trialIlana Oren, Hannah Sprecher, Renato Finkelstein, et al.Annals of Hematology|January 7, 2017
Second line azacitidine for elderly or infirmed patients with acute myeloid leukemia (AML) not eligible for allogeneic hematopoietic cell transplantation-a retrospective national multicenter studyRon Ram, Moshe Gatt, Drorit Merkel, et al.Blood Advances|November 27, 2019
BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a studyTsila Zuckerman, Ron Ram, Luiza Akria, et al.Current Opinion in Hematology|January 12, 2018
Revisiting autologous transplantation in acute myeloid leukemiaChezi Ganzel, Jacob M RowePageof 29